Catalyst Wire Dossier Catalyst Wire Dossier

Elsiglutide

elsiglutide · Helsinn Healthcare SA
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Elsiglutide, covering 2014-03-26 to 2024-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID) [Phase 2]

See pricing